Eric S. Langer || November 6, 2008 Bio News & Views: Bio-Outsourcing Trends
A new study explores capacity and production issues
By Eric S. Langer
Outsourcing biopharmaceutical production has become increasingly common during the past decade, with more than half of…
Gil Roth || February 25, 2008 SAFC Builds Bio-CMO Capacity
by Gil Roth
In May 2007, Sigma Aldrich Fine Chemicals (SAFC) acquired Molecular Medicine BioServices, Inc. (MMB), a Carlsbad, CA-based bio-CMO with a focus on vaccines and gene therapy products. Earlier this yea…
April 4, 2006 Rise of the Biogenerics?
Will generic competition invade the biologic space?
By Gil Y. Roth
When will generic biopharmaceuticals reach the marketplace? While some treat their presence in the marketplace as an inevitability, oth…